跳至主要内容
临床试验/ACTRN12611001208998
ACTRN12611001208998招募中未知

Randomized placebo controlled trial of probiotics in overweight and obese women to assess the prevention of gestational diabetes

Royal Brisbane and Women's Hospital0 个研究点目标入组 540 人开始时间: 2011年11月23日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
540

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • BMI greater than 25
  • Can read and understand English
  • Less than 16 weeks pregnant

排除标准

  • Gestation >16 weeks
  • Pre-existing type 1 or type 2 diabetes
  • Pre-existing impaired fasting glucose or impaired glucose tolerance
  • GDM on early screening
  • Medications likely to influence glucose metabolism (eg metformin, glucocorticoids, immunosuppressants)
  • Medical conditions associated with altered glucose metabolism -eg Cushings, cirrhosis of the liver
  • Known fetal abnormality on the 12-13 week ultrasound scan
  • Known ingestion of probiotics via capsule

研究者

相似试验